Skip to main content

Published locations for TP53-mutated AML: No survival benefit with addition of venetoclax to standard therapies

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. TP53-mutated AML: No survival benefit with addition of venetoclax to standard therapies

User login

  • Reset your password
  • /content/tp53-mutated-aml-no-survival-benefit-addition-venetoclax-standard-therapies
  • /hematology-oncology/article/243647/aml/tp53-mutated-aml-no-survival-benefit-addition-venetoclax